Clinical response and tricyclic plasma levels during treatment with clomipramine - PubMed (original) (raw)
Clinical response and tricyclic plasma levels during treatment with clomipramine
L Della Corte et al. Br J Psychiatry. 1979 Apr.
Abstract
Fifty depressed in-patients at two psychiatric units, one in Italy the other in England, were treated with clomipramine, either orally, or intravenously and orally. A comparison of clinical response with plasma levels of clomipramine and its metabolite, desmethylclomipramine, showed clear relationships especially in the case of desmethylclomipramine. In the intravenously-treated group this was linear, in the orally-treated group it was curvilinear. Plasma levels of desmethylclomipramine and administered clomipramine correlate highly. These findings, together with the fact that significant clinical improvement was observed in only 55% of the patients, suggest that titration of the administered dose to obtain more effective plasma levels of the metabolite might improve the clinical response to the drug in some patients.
Similar articles
- Plasma level studies of clomipramine and desmethylclomipramine following intravenous infusions of clomipramine in depressive patients.
Luscombe DK, Wright J, Jain VK. Luscombe DK, et al. Postgrad Med J. 1977;53 Suppl 4:88-96. Postgrad Med J. 1977. PMID: 600900 No abstract available. - Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients.
Montgomery SA, McAuley R, Montgomery DB, Dawling S, Braithwaite RA. Montgomery SA, et al. Postgrad Med J. 1980;56 Suppl 1:130-3. Postgrad Med J. 1980. PMID: 7393823 - A clinical trial of a 50 mg formulation of clomipramine (Anafranil) with steady-state plasma level measurements.
Gringras M, Luscombe DK, Jones RB, Beaumont G, Seldrup J, John V. Gringras M, et al. J Int Med Res. 1977;5(1 Suppl):119-24. J Int Med Res. 1977. PMID: 863081 - Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer.
Brown JT, Schneiderhan M, Eum S, Bishop JR. Brown JT, et al. Pharmacogenomics. 2017 May;18(7):601-605. doi: 10.2217/pgs-2017-0015. Epub 2017 May 4. Pharmacogenomics. 2017. PMID: 28470111 Review. - Practical considerations on the use of clomipramine (Anafranil) in general practice: an updated review.
Beaumont G. Beaumont G. J Int Med Res. 1977;5(1 Suppl):46-50. J Int Med Res. 1977. PMID: 324832 Review.
Cited by
- Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux.
Rossi M, Munarriz ER, Bartesaghi S, Milanese M, Dinsdale D, Guerra-Martin MA, Bampton ET, Glynn P, Bonanno G, Knight RA, Nicotera P, Melino G. Rossi M, et al. J Cell Sci. 2009 Sep 15;122(Pt 18):3330-9. doi: 10.1242/jcs.048181. Epub 2009 Aug 25. J Cell Sci. 2009. PMID: 19706685 Free PMC article. - Current antidepressant drugs: their clinical use.
Hollister LE. Hollister LE. Drugs. 1981 Aug;22(2):129-52. doi: 10.2165/00003495-198122020-00003. Drugs. 1981. PMID: 6114851 Review. - Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.
Lassen JB, Lund J, Søndergaard I. Lassen JB, et al. Psychopharmacology (Berl). 1980;68(3):229-33. doi: 10.1007/BF00428108. Psychopharmacology (Berl). 1980. PMID: 6446724 No abstract available. - Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data.
Gex-Fabry M, Balant-Gorgia AE, Balant LP, Garrone G. Gex-Fabry M, et al. Clin Pharmacokinet. 1990 Sep;19(3):241-55. doi: 10.2165/00003088-199019030-00007. Clin Pharmacokinet. 1990. PMID: 2394063 - Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response.
Vandel B, Vandel S, Jounet JM, Allers G, Volmat R. Vandel B, et al. Eur J Clin Pharmacol. 1982;22(1):15-20. doi: 10.1007/BF00606419. Eur J Clin Pharmacol. 1982. PMID: 7094971 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources